419
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Antibiotic Resistance and Molecular Epidemiology of Vancomycin-Resistant Enterococci in a Tertiary Care Hospital in Turkey

ORCID Icon &
Pages 191-198 | Published online: 21 Jan 2020

References

  • Cesar AA, Murray BE. Enterococcus species, streptococcus gallolyticus group, and leuconostoc species In: Bennet JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Philadelphia (PA): Elsevier Inc.; 2015:2328–2339.
  • Reyes K, Bardossy AC, Zervos M. Vancomycin-resistant enterococci: epidemiology, infection prevention, and control. Infect Dis Clin North Am. 2016;30(4):953–965. doi:10.1016/j.idc.2016.07.00927660091
  • Dziri R, Lozano C, Ben Said L, et al. Multidrug-resistant enterococci in the hospital environment: detection of novel vancomycin-resistant E. faecium clone ST910. J Infect Dev Ctries. 2016;10(8):799–806. doi:10.3855/jidc.801427580324
  • Faron ML, Ledeboer NA, Buchan BW, Kraft CS. Resistance mechanisms, epidemiology, and approaches to screening for vancomycin-resistant enterococcus in the health care setting. J Clin Microbiol. 2016;54(10):2436–2447. doi:10.1128/JCM.00211-1627147728
  • Hollenbeck BL, Rice LB. Intrinsic and acquired resistance mechanisms in enterococcus. Virulence. 2012;3(5):421–433. doi:10.4161/viru.2128223076243
  • O’Driscoll T, Crank CW. Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist. 2015;8:217–230. doi:10.2147/IDR.S5412526244026
  • Guzman Prieto AM, van Schaik W, Rogers MRC, et al. Global emergence and dissemination of enterococci as nosocomial pathogens: attack of the clones?. Front Microbiol. 2016;7(5):1–15. doi:10.3389/fmicb.2016.0078826834723
  • Yang JX, Li T, Ning YZ, et al. Molecular characterization of resistance, virulence and clonality in vancomycin-resistant enterococcus faecium and enterococcus faecalis: A hospital-based study in Beijing, China. Infect Genet Evol. 2015;33:253–260. doi:10.1016/j.meegid.2015.05.01225976380
  • CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 27th Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
  • Nasaj M, Mousavi SM, Hosseini SM, Arabestani MR. Prevalence of virulence factors and vancomycin-resistant genes among Enterococcus faecalis and E. faecium isolated from clinical specimens. Iran J Public Health. 2016;45(6):806–813.27648425
  • Güldemir D, Karagoz A, Dal T, Tekin A, Ozekinci T, Durmaz R. Molecular typing of nosocomial enterococci by pulsed-field gel electrophoresis. Turk Hij Den Biyol Derg. 2015;72(1):1–10. doi:10.5505/TurkHijyen.2015.94695
  • World Health Organization (WHO). WHO Publishes List of Bacteria for Which New Antibiotics are Urgently Needed. Geneva, Switzerland; 2017 Available from https://www.who.int/news-room/detail/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. Accessed 418, 2019.
  • Gozalan A, Coskun-Ari FF, Ozdem B, et al. Molecular characterization of vancomycin-resistant Enterococcus faecium strains isolated from carriage and clinical samples in a tertiary hospital, Turkey. J Med Microbiol. 2015;64(7):759–766. doi:10.1099/jmm.0.00008825976005
  • Terkuran M, Erginkaya Z, Unal E, Guran M, Kizilyildirim S, Gökce U. The relationship between virulence factors and vancomycin resistance among Enterococci collected from food and human samples in Southern Turkey. Ankara Univ Vet Fak Derg. 2014;61:133–140.
  • Uludag HA, Ataman CH, Bulut C, Eser OK, Demiröz AP. Comparison of GeneXpert® vanA/vanB PCR system and culture methods in the surveillance of vancomycin-resistant enterococci. Mikrobiyol Bul. 2014;48(4):538–544. doi:10.5578/mb.884825492649
  • Arslan U, Demir E, Oryasin E, et al. MLST types of vancomycin-resistant enterococcus faecium strains isolated from blood cultures. Mikrobiyol Bul. 2013;47(3):432–441. doi:10.5578/mb.508523971921
  • Coombs GW, Pearson JC, Daley DA, et al. Molecular epidemiology of enterococcal bacteremia in Australia. J Clin Microbiol. 2014;52:897–905. doi:10.1128/JCM.03286-1324391201
  • Marcadé G, Micol J, Jacquier H, et al. Outbreak in a haematology unit involving an unusual strain of glycopeptide-resistant Enterococcus faecium carrying both vanA and vanB genes. J Antimicrob Chemother. 2014;69(2):500–505. doi:10.1093/jac/dkt37624092659
  • Papagiannitsis CC, Malli E, Florou Z, et al. First description in Europe of emergence of enterococcus faecium ST117, carrying both vanA/vanB genes, isolated in Greece. J Glob Antimicrob Resist. 2017;11:68–70. doi:10.1016/j.jgar.2017.07.01028754459
  • Coskun FA, Mumcuoglu I, Aksu N, et al. Phenotypic and genotypic traits of vancomycin-resistant enterococci in a public hospital: the first vanB-positive Enterococcus faecium isolates. Mikrobiyol Bul. 2012;46(2):276–282.22639316
  • European Centre for Disease Prevention and Control. Surveillance Atlas of Infectious Diseases [Internet]. Stockholm: ECDC; 2018 Available from: http://atlas.ecdc.europa.eu. Accessed 612, 2019.
  • Kilbas I, Ciftci IH. Antimicrobial resistance of Enterococcus isolates in Turkey: a meta-analysis of current studies. J Glob Antimicrob Resist. 2018;12:26–30. doi:10.1016/j.jgar.2017.08.01228882763
  • Asadollahi P, Razavi S, Asadollahi K, et al. Rise of antibiotic resistance in clinical enterococcal isolates during 2001–2016 in Iran: a review. New Microbes New Infect. 2018;26:92–99. doi:10.1016/j.nmni.2018.08.01830319780
  • Oh WS, Ko KS, Song JH, et al. High rate of resistance to quinupristin-dalfopristin in Enterococcus faecium clinical isolates from Korea. Antimicrob Agents Chemother. 2005;49(12):5176–5178. doi:10.1128/AAC.49.12.5176-5178.200516304198
  • Central Asian and Eastern European Surveillance of Antimicrobial Resistance (CAESAR) (2018). Annual Report 2017. Available from: http://www.euro.who.int/en/health-topics/disease-prevention/antimicrobial-resistance/publications/2017/central-asian-and-eastern-european-surveillance-of-antimicrobial-resistance.-annual-report-2017-2018. Accessed 328, 2019.
  • Nayak PP, Biranthabail D, Shenoy S, Kotian SM. Antibiogram and genetic relatedness of clinical isolates of Enterococcus spp. in Mangalore, India. J Infect Dev Ctries. 2018;12(11):985–990. doi:10.3855/jidc.9966
  • Bi R, Qin T, Fan W, Ma P, Gu B. The emerging problem of linezolid-resistant enterococci. J Glob Antimicrob Resist. 2018;13:11–19. doi:10.1016/j.jgar.2017.10.01829101082
  • Bender JK, Cattoir V, Hegstad K, et al. Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: towards a common nomenclature. Drug Resist Updat. 2018;40:25–39. doi:10.1016/j.drup.2018.10.00230447411
  • Moosavian M, Ghadri H, Samli Z. Molecular detection of van A and van B genes among vancomycin-resistant enterococci in ICU hospitalized patients in Ahvaz in southwest of Iran. Infect Drug Resist. 2018;11:2269–2275. doi:10.2147/IDR.S17788630532561
  • Simner PJ, Adam H, Baxter M, et al. Epidemiology of vancomycin-resistant Enterococci in Canadian hospitals (CANWARD Study, 2007 to 2013). Antimicrob Agents Chemother. 2015;59(7):4315–4317. doi:10.1128/AAC.00384-1525896693
  • Lellek H, Franke GC, Ruckert C, et al. Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy. Int J Med Microbiol. 2015;305(8):902–909. doi:10.1016/j.ijmm.2015.09.00526454536
  • Baylan O, Nazik H, Bektöre B, et al. The relationship between antibiotic resistance and virulence factors in urinary Enterococcus isolates. Mikrobiyol Bul. 2011;45(3):430–445.21935776
  • Baysallar M, Kilic A, Aydogan H, Cilli F, Doganci L. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey. Int J Antimicrob Agents. 2004;23(5):510–512. doi:10.1016/j.ijantimicag.2003.09.02915120733
  • Mercuro NJ, Davis SL, Zervos MJ, Herc ES. Combatting resistant enterococcal infections: a pharmacotherapy review. Expert Opin Pharmacother. 2018;19(9):979–992. doi:10.1080/14656566.2018.147939729877755
  • Isogai N, Urushibara N, Kawaguchiya M, et al. Characterization of enterococcus faecium with macrolide resistance and reduced susceptibility to quinupristin/dalfopristin in a Japanese hospital: detection of extensive diversity in erm(B)-regulator regions. Microb Drug Resist. 2013;19(4):298–307. doi:10.1089/mdr.2012.017623442208
  • Monteserin N, Larson E. Temporal trends and risk factors for healthcare-associated vancomycin-resistant enterococci in adults. J Hosp Infect. 2016;94(3):236–241. doi:10.1016/j.jhin.2016.07.02327645212
  • Bressan R, Knezevich A, Monticelli J, et al. Spread of vancomycin-resistant Enterococcus faecium Isolates despite validated infection control measures in an Italian hospital: antibiotic resistance and genotypic characterization of the endemic strain. Microb Drug Resist. 2018;24(8):1148–1155. doi:10.1089/mdr.2017.031429373085
  • Lytsy B, Engstrand L, Gustafsson Å, Kaden R. Time to review the gold standard for genotyping vancomycin-resistant enterococci in epidemiology: comparing whole-genome sequencing with PFGE and MLST in three suspected outbreaks in Sweden during 2013–2015. Infect Genet Evol. 2017;54:74–80. doi:10.1016/j.meegid.2017.06.01028627467
  • Pulsed-field Gel Electrophoresis (PFGE). Centers for Disease Control and Prevention. Available from: https://www.cdc.gov/pulsenet/pathogens/pfge.html. Accessed 1014, 2019.
  • Benammar S, Pantel A, Aujoulat F, et al. First molecular characterization of related cases of healthcare-associated infections involving multidrug-resistant Enterococcus faecium vanA in Algeria. Infect Drug Resist. 2018;11:1483–1490. doi:10.2147/IDR.S16448730271181